Search
Salarius Pharmaceuticals Ord Shs
DCOYAdd to Watchlist
3.100USD
+0.540+21.09%
Close 09-22 16:00（ET）
1.64MMarket Cap
LossP/E TTM
Pre-market 07:20 (ET)4.440USD+1.340+43.23%
Pre-market 07:20 (ET)About Company
Salarius Pharmaceuticals Ord Shs Profile
Ticker Symbol- -
Company name- -
IPO date- -
CEO- -
Number of employees- -
Security type- -
Fiscal year-end- -
Address- -
City- -
Stock exchange- -
Country- -
Postal code- -
Phone- -
Website- -
Ticker Symbol- -
IPO date- -
CEO- -
Company Executives of Salarius Pharmaceuticals Ord Shs
Name
Name/Position
Position
Shareholding
Change
Mr. Mark J. Rosenblum, CPA
Mr. Mark J. Rosenblum, CPA
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
11.36K
+85.21%
Mr. Mark J. Rosenblum, CPA
Mr. Mark J. Rosenblum, CPA
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
11.36K
+85.21%
Mr. Peter Marschel
Mr. Peter Marschel
Chief Business Officer
Chief Business Officer
3.90K
--
Mr. Peter Marschel
Mr. Peter Marschel
Chief Business Officer
Chief Business Officer
3.90K
--
Ms. Tess Burleson
Ms. Tess Burleson
Independent Director
Independent Director
2.00K
+99.90%
Mr. Jonathan I. (Jon) Lieber
Mr. Jonathan I. (Jon) Lieber
Independent Director
Independent Director
2.00K
+99.90%
Ms. Tess Burleson
Ms. Tess Burleson
Independent Director
Independent Director
2.00K
+99.90%
Mr. Jonathan I. (Jon) Lieber
Mr. Jonathan I. (Jon) Lieber
Independent Director
Independent Director
2.00K
+99.90%
Mr. David J. Arthur
Mr. David J. Arthur
Director
Director
34.00
--
Mr. David J. Arthur
Mr. David J. Arthur
Director
Director
34.00
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Mark J. Rosenblum, CPA
Mr. Mark J. Rosenblum, CPA
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
11.36K
+85.21%
Mr. Mark J. Rosenblum, CPA
Mr. Mark J. Rosenblum, CPA
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
11.36K
+85.21%
Mr. Peter Marschel
Mr. Peter Marschel
Chief Business Officer
Chief Business Officer
3.90K
--
Mr. Peter Marschel
Mr. Peter Marschel
Chief Business Officer
Chief Business Officer
3.90K
--
Ms. Tess Burleson
Ms. Tess Burleson
Independent Director
Independent Director
2.00K
+99.90%
Mr. Jonathan I. (Jon) Lieber
Mr. Jonathan I. (Jon) Lieber
Independent Director
Independent Director
2.00K
+99.90%
FAQs
Who are the top five shareholders of Salarius Pharmaceuticals Ord Shs?
The top five shareholders of Salarius Pharmaceuticals Ord Shs are: Mr. Mark J. Rosenblum, CPA
How many institutions hold shares of Salarius Pharmaceuticals Ord Shs (DCOY)?
As of 2026Q1, 24 institutions hold shares of Salarius Pharmaceuticals Ord Shs, with a combined market value of approximately 63.48K, accounting for 11.93% of the total shares. Compared to 2025Q4, institutional shareholding has increased by 34985.00.